ARA-290 does not trigger that pathway
Drug Interactions Drug interactions show low risk with most medications but notable considerations include: Zinc supplements: Compete with copper absorption, may affect copper metabolism and GHK-Cu efficacy Birth control pills: Can affect copper metabolism and levels Certain antibiotics: Some may affect copper absorption/utilization Copper-chelating medications: Directly antagonistic to GHK-Cu, should not be used concurrently Copper Overload Realistic Assessment Theoretical concerns about copper toxicity contrast sharply with actual risk at recommended doses

So, functionalization approaches of NPs based on cationic proteins and short amphipathic/cationic cell penetrating peptides (CPP), such as Syn-B-based vectors (i.e., a peptide derived from an antimicrobial peptide with high affinity for biological membranes) (Kokryakov et al., 1993) or TAT peptides (i.e., derived from the transcription activating factor of human immunodeficiency virus) (Vivs et al., 1997), are considered the most suitable strategies for brain drug delivery
BRCA mutations, Lynch syndrome, Li-Fraumeni syndrome, and other hereditary cancer syndromes create environments where additional risk factors deserve careful consideration
High levels of stress hormones can lead to increased oxidative damage